Risk assessment in fever and neutropenia in children with cancer: What did we learn?
about
Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropeniaOutpatient management of febrile neutropenia in children with cancerThe diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia.Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009.Adverse drug reaction-related admissions in paediatrics, a prospective single-centre study.Chemotherapy-induced neutropenia among pediatric cancer patients in Egypt: Risks and consequencesApproach to Non-Neutropenic Fever in Pediatric Oncology Patients-A Single Institution Study.Evaluation of factors associated with prolonged hospital stay and outcome of febrile neutropenic patients receiving chemotherapy: 70 cases (1997-2010).First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.Serious medical complications in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity*.Predicting bacterial infections among pediatric cancer patients with febrile neutropenia: External validation of the PICNICC model.
P2860
Q24186114-7B774A34-F9A1-4CD6-88C6-DE7C9DF26CA8Q35010364-B7B3B523-E489-42D1-A8AB-CE6401A9D343Q35195245-27F6F69F-6D45-4205-B342-4423AC47EE00Q35625969-BB08372A-2D21-4D02-9F18-D9336427AB2CQ36205536-BF01475D-C98A-46B7-B17D-EE24E8324CAFQ37204380-0D416E8D-A9D6-4CB5-9857-D13E5A5981B5Q38984766-B215A5F0-A509-4768-8EE1-185477DD9E95Q40273644-844D4B31-86D8-4FA9-BD95-3182F80FE330Q40298464-EB7EA6DA-A224-432D-813F-D074A24FFEF6Q40315460-392B78AF-3327-43A0-AE1E-793118405658Q40337681-C41CA29B-8C38-4908-BE33-9C0BA5A57BC0Q47234627-8109CA5C-46C7-4D12-9545-E917579CBB35
P2860
Risk assessment in fever and neutropenia in children with cancer: What did we learn?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk assessment in fever and neutropenia in children with cancer: What did we learn?
@en
Risk assessment in fever and neutropenia in children with cancer: What did we learn?
@nl
type
label
Risk assessment in fever and neutropenia in children with cancer: What did we learn?
@en
Risk assessment in fever and neutropenia in children with cancer: What did we learn?
@nl
prefLabel
Risk assessment in fever and neutropenia in children with cancer: What did we learn?
@en
Risk assessment in fever and neutropenia in children with cancer: What did we learn?
@nl
P2093
P1476
Risk assessment in fever and neutropenia in children with cancer: What did we learn?
@en
P2093
Esther M te Poele
Eveline S J M de Bont
Willem A Kamps
Wim J E Tissing
P356
10.1016/J.CRITREVONC.2008.12.009
P577
2009-02-04T00:00:00Z